Model JC200 Focused Ultrasound Tumor Therapeutic System

Non-invasive, extracorporeal ultrasound ablation treatment of tumors

Download the brochure of JC200

Indications

Solid tumors of all types of soft tissues such as:

Benign:

• Benign gynecologic tumors such as uterine fibroids

Malignant:

Contraindications
•  Tumor of head 
•  Tumor in spine and vertebral canal 
•  Tumor of gastrointestinal tract
•  Tumor in thoracic cavity 
•  Tumor of hollow viscous with obstruction

Clinical Advangtages
• Noninvasive treatment to preserve organs and structures, with no blood transfusion and no radiation
• Conformal and precise ablation
• One time treatment, no limitation by tumor size and shape
• Real-time ultrasound-guided therapy with digital quantitative analysis
• Activation of immune system

Approvals: Europe: CE, China: CFDA

Package Price: three million and two hundred thousand US dollars ($3,200,000) to three million and nine hundred thousand US dollars ($3,900,000), including: